DIVISION OF HEMATOLOGY/ONCOLOGY RESEARCH CONFERENCE
Contact: Caitlin Vuocolo at x4-8100
(http://www.med.umich.edu/i/cancer/hemoncchedule.htm)
Supported in part by Celgene, Genentech
Inc., Pharmion Corporation, Chiron Corporation,
Eli Lilly and Company and Pfizer Inc.
The objective of this series is to inform physicians
and other health care professionals of advances
and their scientific basis across various fields
within Hematology/Oncology.
The University of Michigan Medical School is
accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to sponsor
continuing medical education for physicians.
The University of Michigan Medical School designates
this educational activity for a maximum of 1
category 1 credit toward the AMA Physician’s
Recognition award. Each physician should claim
only those credits that he/she actually spent
in the educational activity.
Contact person: Caitlin Vuocolo, 4-8100
http://www.med.umich.edu/i/cancer/hemoncchedule.htm
Click here for updated Tumor Board schedule |
